Cited by 1,690Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancerChromatin Remodeling and Cancer

The DOI matches its Crossref record; 115 of the 122 references it cites were found in a registry or an index.

The RB and p53 pathways in cancer

Open access

Sherr, Charles J, McCormick, Frank·2002·Cancer Cell

Open this paper in CoChat — free account Open PDF

Abstract

The life history of cancer cells encompasses a series of genetic missteps in which normal cells are progressively transformed into tumor cells that invade surrounding tissues and become malignant. Most prominent among the regulators disrupted in cancer cells are two tumor suppressors, the retinoblastoma protein (RB) and the p53 transcription factor. Here, we discuss interconnecting signaling pathways controlled by RB and p53, attempting to explain their potentially universal involvement in the etiology of cancer. Pinpointing the various ways by which the functions of RB and p53 are subverted in individual tumors should provide a rational basis for developing more refined tumor-specific therapies.

Integrity signals

Registry

Crossref · 10.1016/s1535-6108(02)00102-2

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Self-citation
Cancer Cell Cycles
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Self-citation
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“By inducing Arf and Ink4a in primary rodent fibroblasts, oncogenic Ras expression leads to growth arrest and premature senescence (Serrano et al., 1997; Ferbeyre et al., 2002).”
Background
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
Safety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
Untitled work
Johnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585

Show all 122 references

Sorted by citations

Items 101–200 of 1,000

Genomic Aberrations that Activate D-type Cyclins Are Associated with Enhanced Sensitivity to the CDK4 and CDK6 Inhibitor Abemaciclib
Gong, X., Litchfield, L. M., Webster, Y., Chio, L.-C., Wong, S. S., Stewart, T. R., Dowless, M. S., Dempsey, J. A., Zeng, Y. A., Torres, R., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.11.006 · Cited by 246
Cell-Cycle Control of Gene Expression in Budding and Fission Yeast
Bähler, J. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095808 · Cited by 235
Pathogenesis of Non-Hodgkin's Lymphoma
Nogai, H., Dörken, B., & Lenz, G. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.3252 · Cited by 232
MDMX: from bench to bedside
Marine, J.-C. W., Dyer, M. A., & Jochemsen, A. G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03362 · Cited by 228
Targeting the nucleolus for cancer intervention
Quin, J. E., Devlin, J. R., Cameron, D. P., Hannan, K. M., Pearson, R. B., & Hannan, R. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.009 · Cited by 230
Methylation of the Retinoblastoma Tumor Suppressor by SMYD2
Saddic, L., West, L. E., Aslanian, A., Yates, J. R., Rubin, S. M., Gozani, O., & Sage, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.137612 · Cited by 226
Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM
Wiedemeyer, W. R., Dunn, I. F., Quayle, S. N., Zhang, J., Chheda, M. G., Dunn, G. P., Zhuang, L., Rosenbluh, J., Chen, S., Xiao, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001613107 · Cited by 223
Roads to melanoma: Key pathways and emerging players in melanoma progression and oncogenic signaling
Paluncic, J., Kovačević, Ž., Jansson, P. J., Kalinowski, D. S., Merlot, A. M., Huang, M., Lok, H. C., Sahni, S., Lane, D. J. R., & Richardson, D. R. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.025 · Cited by 236
Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis
Reid‐Nicholson, M. D., Iyengar, P., Hummer, A., Linkov, I., Asher, M., & Soslow, R. A. (2006) · Modern Pathology · doi:10.1038/modpathol.3800620 · Cited by 218
Cyclin D1 Splice Variants
Solomon, D. A., Wang, Y., Fox, S. R., Lambeck, T. C., Giesting, S., Lan, Z., Senderowicz, A. M., & Knudsen, E. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303969200 · Cited by 223
Relevance of the p53–MDM2 axis to aging
Wu, D., & Prives, C. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.187 · Cited by 215
The c‐myc Promoter: Still MysterY and Challenge
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99004-1 · Cited by 211
A Genetic Progression Model of BrafV600E-Induced Intestinal Tumorigenesis Reveals Targets for Therapeutic Intervention
Rad, R., Cadiñanos, J., Rad, L., Varela, I., Strong, A., Kriegl, L., Constantino‐Casas, F., Eser, S., Hieber, M., Seidler, B., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.014 · Cited by 227
GlcNAcylation Plays an Essential Role in Breast Cancer Metastasis
Gu, Y., Mi, W., Ge, Y., Liu, H., Fan, Q., Han, C., Yang, J., Han, F., Lu, X., & Yu, W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1887 · Cited by 222
Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. “Alive, with good vision and no comorbidity”
Munier, F. L., Popovic, M. B., Chantada, G. L., Cobrinik, D. E., Kivelä, T., Lohmann, D. R., Maeder, P. P., Moll, A. C., Carcaboso, A. M., Moulin, A., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.05.005 · Cited by 214
Pathogenesis of Mantle-Cell Lymphoma: All Oncogenic Roads Lead to Dysregulation of Cell Cycle and DNA Damage Response Pathways
Fernández, V., Hartmann, E., Ott, G., Campo, E., & Rosenwald, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.019 · Cited by 214
RB1 Methylation by SMYD2 Enhances Cell Cycle Progression through an Increase of RB1 Phosphorylation
Cho, H., Hayami, S., Toyokawa, G., Maejima, K., Yamane, Y., Suzuki, T., Dohmae, N., Kogure, M., Kang, D., Neal, D. E., et al. (2012) · Neoplasia · doi:10.1593/neo.12656 · Cited by 209
Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers
Dumont, N., Wilson, M. B., Crawford, Y., Reynolds, P. A., Sigaroudinia, M., & Tlsty, T. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807146105 · Cited by 210
Topoisomerase IIα in chromosome instability and personalized cancer therapy
Chen, T., Sun, Y. K., Ji, P., Kopetz, S., & Zhang, W. (2014) · Oncogene · doi:10.1038/onc.2014.332 · Cited by 207
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma
Gounder, M. M., Agaram, N. P., Trabucco, S. E., Robinson, V. L., Ferraro, R., Millis, S. Z., Krishnan, A., Lee, J., Attia, S., Abida, W. M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30496-0 · Cited by 221
Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
Piezzo, M., Cocco, S., Caputo, R., Cianniello, D., Gioia, G. D., Lauro, V. D., Fusco, G., Martinelli, C., Nuzzo, F., Pensabene, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186479 · Cited by 212
Activating Transcription Factor 3, a Stress-inducible Gene, Suppresses Ras-stimulated Tumorigenesis
Lü, D., Wolfgang, C. D., & Hai, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509278200 · Cited by 207
RB1, Development, and Cancer
Chinnam, M., & Goodrich, D. W. (2011) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00005-x · Cited by 206
Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia
Williams, R. T., Roussel, M. F., & Sherr, C. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602030103 · Cited by 191
Self-citation
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer
Bosco, E. E., Wang, Y., Xu, H., Zilfou, J. T., Knudsen, K. E., Aronow, B. J., Lowe, S. W., & Knudsen, E. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28803 · Cited by 192
Regulation of the cytoskeleton: an oncogenic function for cdk inhibitors?
Besson, A., Assoian, R. K., & Roberts, J. M. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1501 · Cited by 193
The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications
Honrado, E., Benitez, J. J., & Palacios, J. (2005) · Modern Pathology · doi:10.1038/modpathol.3800453 · Cited by 192
Clinical update on cancer: molecular oncology of head and neck cancer
Suh, Y., Amelio, I., Urbano, T. G., & Tavassoli, M. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.548 · Cited by 195
Assessing cell and organ senescence biomarkers
de Jesus, B. B., & Blasco, M. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.247866 · Cited by 187
Detection of Bladder Cancer in Urine by a Tumor Suppressor Gene Hypermethylation Panel
Dulaimi, E., Uzzo, R. G., Greenberg, R. E., Al‐Saleem, T., & Cairns, P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0127 · Cited by 188
Merkel Cell Polyomavirus Infection, Large T Antigen, Retinoblastoma Protein and Outcome in Merkel Cell Carcinoma
Sihto, H. J., Kukko, H., Koljonen, V., Sankila, R. J., Böhling, T., & Joensuu, H. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3363 · Cited by 184
Papillomavirus E6 and E7 proteins and their cellular targets
Wise-Draper, T. M. (2007) · Frontiers in bioscience · doi:10.2741/2739 · Cited by 183
Genetic Analysis of Chromosome Pairing, Recombination, and Cell Cycle Control during First Meiotic Prophase in Mammals
Cohen, P. E., Pollack, S. E., & Pollard, J. W. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0017 · Cited by 189
FOXM1 (Forkhead box M1) in Tumorigenesis
Wierstra, I. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00016-2 · Cited by 190
miR-15 and miR-16 Are Direct Transcriptional Targets of E2F1 that Limit E2F-Induced Proliferation by Targeting Cyclin E
Ofir, M., Hacohen, D., & Ginsberg, D. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0344 · Cited by 190
Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach
Chen, L., & Cui, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160922830 · Cited by 184
Cell Cycle Regulation During Viral Infection
Bagga, S., & Bouchard, M. J. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0888-2_10 · Cited by 187
The Transcription Factor FOXM1 (Forkhead box M1)
Wierstra, I. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407173-5.00004-2 · Cited by 180
Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia
Christiansen, D. H., Andersen, M. K., & Pedersen-Bjergaard, J. (2003) · Leukemia · doi:10.1038/sj.leu.2403054 · Cited by 176
Ribosome Biogenesis and Control of Cell Proliferation: p53 Is Not Alone
Donati, G., Montanaro, L., & Derenzini, M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3992 · Cited by 175
Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging
Adams, P. D. (2007) · Gene · doi:10.1016/j.gene.2007.04.020 · Cited by 182
Non-canonical functions of the RB protein in cancer
Dick, F. A., Goodrich, D. W., Sage, J., & Dyson, N. J. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0008-5 · Cited by 175
p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewalPreprint
Zhao, Z., Zuber, J. A., Díaz-Flores, E., Lintault, L., Kogan, S. C., Shannon, K., & Lowe, S. W. (2010) · Genes & Development · doi:10.1101/gad.1940710 · Cited by 175
BAF180 Is a Critical Regulator of p21 Induction and a Tumor Suppressor Mutated in Breast Cancer
Xia, W., Nagase, S., Montia, A. G., Kalachikov, S. M., Keniry, M. E., Su, T., Memeo, L., Hibshoosh, H. H., & Parsons, R. E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5276 · Cited by 166
Increased expression of long noncoding RNA TUG1 predicts a poor prognosis of gastric cancer and regulates cell proliferation by epigenetically silencing of p57
Zhang, E., He, X., Yin, D., Han, L., Qiu, M., Xu, T., Xia, R., Xu, L., Yin, R. H., & De, W. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.356 · Cited by 165
Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers
Palacios, J., Honrado, E., Osório, A., Cazorla, A., Sarrió, D., Barroso, A., Rodríguez, S., Cigudosa, J. C., Dı́ez, O., Alonso, C., et al. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-1536-0 · Cited by 164
Strong expression of a longevity-related protein, SIRT1, in Bowen’s disease
Hida, Y., Kubo, Y., Murao, K., & Arase, S. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0725-6 · Cited by 161
Involvement of E2F transcription factor family in cancer
Tsantoulis, P. K., & Gorgoulis, V. G. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.005 · Cited by 166
Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21Waf1/Cip1
Borgdorff, V, Lleonart, M. E., Bishop, C. L., Fessart, D., Bergin, A. H., Overhoff, M. G., & Beach, D. H. (2010) · Oncogene · doi:10.1038/onc.2009.497 · Cited by 160
Minireview: Basal-Like Breast Cancer: From Molecular Profiles to Targeted Therapies
Toft, D. J., & Cryns, V. L. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0164 · Cited by 173
Regulation of NF‐κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor
Rocha, S., Garrett, M. D., Campbell, K. J., Schumm, K., & Perkins, N. D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600608 · Cited by 161
Molecular Characterization of Spontaneous Mesenchymal Stem Cell Transformation
Rubio, D., García, S., Paz, M. F., de la Cueva, T., López-Fernández, L. A., Lloyd, A. C., Garcı́a-Castro, J., & Bernad, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001398 · Cited by 166
Definition of pRB- and p53-Dependent and -Independent Steps in HIRA/ASF1a-Mediated Formation of Senescence-Associated Heterochromatin Foci
Ye, X., Zerlanko, B. J., Zhang, R., Somaiah, N., Lipinski, M., Salomoni, P., & Adams, P. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01592-06 · Cited by 177
p16 Is Required for hSNF5 Chromatin Remodeler-induced Cellular Senescence in Malignant Rhabdoid Tumor Cells
Oruetxebarria, I., Venturini, F., Kekarainen, T., Houweling, A., Zuijderduijn, L. M. P., Mohd-Sarip, A., Vries, R. G. J., Hoeben, R. C., & Verrijzer, C. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309333200 · Cited by 164
Aberrant Regulation of Survivin by the RB/E2F Family of Proteins
Jiang, Y., Saavedra, H. I., Holloway, M. P., Leone, G. W., & Altura, R. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404496200 · Cited by 159
The role of B-RAF in melanoma
Gray‐Schopfer, V. C., Dias, S. D. R., & Marais, R. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-5865-1 · Cited by 156
Cell cycle progression and de novo centriole assembly after centrosomal removal in untransformed human cells
Uetake, Y., Lončarek, J., Nordberg, J. J., English, C. N., Terra, S. L., Khodjakov, A. L., & Sluder, G. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200607073 · Cited by 165
p53 Stabilization and Accumulation Induced by Human Vaccinia-Related Kinase 1
Vega, F. M. D. L., Sevilla, A., & Lazo, P. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.23.10366-10380.2004 · Cited by 155
Molecular‐genetic insights in paediatric T‐cell acute lymphoblastic leukaemia
Vlierberghe, P. V., Pieters, R., Beverloo, H. B., & Meijerink, J. P. P. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07314.x · Cited by 166
Promoter Hypermethylation Profile of Kidney Cancer
Dulaimi, E., de Cáceres, I. I., Uzzo, R. G., Al‐Saleem, T., Greenberg, R. E., Polascik, T. J., Babb, J. S., Grizzle, W. E., & Cairns, P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0175 · Cited by 157
Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance
Taneja, P., Maglic, D., Kai, F., Zhu, S., Kendig, R. D., Elizabeth, A., & Inoue, K. (2010) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s4773 · Cited by 160
Phosphorylation of Serine 18 Regulates Distinct p53 Functions in Mice
Sluss, H. K., Armata, H., Gallant, J., & Jones, S. N. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.976-984.2004 · Cited by 152
p27 as a target for cancer therapeutics
Blain, S. W., Scher, H. I., Cordon‐Cardo, C., & Koff, A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00026-6 · Cited by 153
The role of exosomes and microRNAs in senescence and aging
Xu, D., & Tahara, H. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.010 · Cited by 154
Aurora A ligand complex
Antonysamy, S., Pustilnik, A., Manglicmot, D., Froning, K., Weichert, K., & Wasserman, S. (2018) · Worldwide Protein Data Bank · doi:10.2210/pdb6c2r/pdb · Cited by 148
5-Aza-2′-deoxycytidine Activates the p53/p21Waf1/Cip1 Pathway to Inhibit Cell Proliferation
Zhu, W., Hileman, T., Ke, Y., Wang, P., Lu, S., Duan, W., Dai, Z., Tong, T., Villalona-Calero, M. A., Plass, C., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311703200 · Cited by 148
Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D
Das, S. K., Hashimoto, T., & Kanazawa, K. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.01.003 · Cited by 151
Senescence as a therapeutically relevant response to CDK4/6 inhibitors
Wagner, V., & Gil, J. (2020) · Oncogene · doi:10.1038/s41388-020-1354-9 · Cited by 148
Advances in cutaneous squamous cell carcinoma
Winge, M. C. G., Kellman, L. N., Guo, K., Tang, J. Y., Swetter, S. M., Aasi, S. Z., Sarin, K. Y., Chang, A. L. S., & Khavari, P. A. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00583-5 · Cited by 150
Inflammatory signaling and cellular senescence
Ren, J., Pan, J., Lu, Y.-P., Sun, P., & Han, J. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.011 · Cited by 153
Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis
Ruiz, S., Santos, M., Segrelles, C., Leis, H., Jorcano, J. L., Berns, A., Paramio, J. M., & Vooijs, M. (2004) · Development · doi:10.1242/dev.01148 · Cited by 147
The Etiologic Role of HPV in Vulvar Squamous Cell Carcinoma Fine Tuned
van de Nieuwenhof, H. P., van Kempen, L. C. L. T., de Hullu, J. A., Bekkers, R. L. M., Bulten, J., Melchers, W. J. G., & Massuger, L. F. A. G. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0209 · Cited by 147
Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model
Uhrbom, L., Nerio, E., & Holland, E. C. (2004) · Nature Medicine · doi:10.1038/nm1120 · Cited by 146
Untitled work
(2003) · PubMed · Cited by 146
p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels
Iyer, N. G., Chin, S., Özdağ, H., Daigo, Y., Hu, D., Cariati, M., Brindle, K. M., Aparicio, S. A. J. R., & Caldas, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401002101 · Cited by 147
MC1R Is a Potent Regulator of PTEN after UV Exposure in Melanocytes
Cao, J., Wan, L., Hacker, E., Dai, X., Lenna, S., Jimenez-Cervantes, C., Wang, Y., Leslie, N. R., Xu, G. X., Widlund, H. R., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.010 · Cited by 144
Protein post-translational modifications in the regulation of cancer hallmarks
Wang, H., Yang, L., Liu, M., & Luo, J. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00464-3 · Cited by 148
Deconstructing the molecular portrait of basal-like breast cancer
Yehiely, F., Moyano, J. V., Evans, J. R., Nielsen, T. O., & Cryns, V. L. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.09.004 · Cited by 144
Curcumin encapsulation in functional PLGA nanoparticles: A promising strategy for cancer therapies
Feltrin, F. D. S., Agner, T., Sayer, C., & Lona, L. M. F. (2021) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2021.102582 · Cited by 144
Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3β-mediated cyclin D1 overexpression
Shimura, T., Kakuda, S., Ochiai, Y., Nakagawa, H., Kuwahara, Y., Takai, Y., Kobayashi, J., Komatsu, K., & Fukumoto, M. (2010) · Oncogene · doi:10.1038/onc.2010.238 · Cited by 143
Tumor Suppressor p16INK4A Regulates Polycomb-mediated DNA Hypermethylation in Human Mammary Epithelial Cells
Reynolds, P. A., Sigaroudinia, M., Zardo, G., Wilson, M. B., Benton, G. M., Miller, C. J., Hong, C., Fridlyand, J., Costello, J., & Tlsty, T. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604175200 · Cited by 137
Gene expression profiling of replicative and induced senescence
Purcell, M., Kruger, A., & Tainsky, M. A. (2014) · Cell Cycle · doi:10.4161/15384101.2014.973327 · Cited by 132
A comprehensive modular map of molecular interactions in RB/E2F pathway
Calzone, L., Gelay, A., Zinovyev, A., Radvanyi, F., & Barillot, E. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.7 · Cited by 132
Long non-coding RNA XIST exerts oncogenic functions in human nasopharyngeal carcinoma by targeting miR-34a-5p
Song, P., Ye, L.-F., Zhang, C., Peng, T., & Zhou, X. (2016) · Gene · doi:10.1016/j.gene.2016.07.055 · Cited by 138
Telomere dysfunction, genome instability and cancer
Annie, L. M. C. (2007) · Frontiers in bioscience · doi:10.2741/2825 · Cited by 137
Proapoptotic Function of the Retinoblastoma Tumor Suppressor Protein
Ianari, A., Natale, T., Calo, E., Ferretti, E., Alesse, E., Screpanti, I., Haigis, K. M., Gulino, A., & Lees, J. A. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.026 · Cited by 142
Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice
Rogers, Z. N., McFarland, C. D., Winters, I. P., Seoane, J. A., Brady Jennifer, J., Yoon, S. M., Curtis, C. N., Petrov, D. A., & Winslow, M. M. (2018) · Nature Genetics · doi:10.1038/s41588-018-0083-2 · Cited by 125
Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein
Kim, J.-H., Chae, M.-J., Kim, W. K., Kim, Y., Kang, H. S., Kim, H. S., & Yoon, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01089.x · Cited by 133
S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type
Javed, H., Khan, M. M., Khan, A., Vaibhav, K., Ahmad, A., Khuwaja, G., Ahmed, M. E., Raza, S. S., Ashafaq, M., Tabassum, R., et al. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.072 · Cited by 133
The Retinoblastoma Protein Regulates Pericentric Heterochromatin
Isaac, C. E., Francis, S. M., Martens, A. L., Julian, L. M., Seifried, L. A., Erdmann, N., Binné, U. K., Harrington, L., Sicinski, P., Bérubé, N. G., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3659-3671.2006 · Cited by 128
Stem Cell Self-Renewal and Cancer Cell Proliferation Are Regulated by Common Networks That Balance the Activation of Proto-oncogenes and Tumor SuppressorsPreprint
Pardal, R., Molofsky, A. V., He, S., & Morrison, S. J. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.057 · Cited by 133
The retinoblastoma protein induces apoptosis directly at the mitochondriaPreprint
Hilgendorf, K. I., Leshchiner, E. S., Nedelcu, S., Maynard, M. A., Calo, E., Ianari, A., Walensky, L. D., & Lees, J. A. (2013) · Genes & Development · doi:10.1101/gad.211326.112 · Cited by 134
Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16 INK4A and p14 ARF expression
Maruo, S., Zhao, B., Johannsen, E., Kieff, E. D., Zou, J., & Takada, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019599108 · Cited by 130
The biological implications of Yin Yang 1 in the hallmarks of cancer
Meliala, I. T. S., Hosea, R., Kasim, V., & Wu, S. (2020) · Theranostics · doi:10.7150/thno.43481 · Cited by 131
Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas
Włodarska, I., Dierickx, D., Vanhentenrijk, V., Roosbroeck, K. V., Pospíšilová, H., Minnei, F., Verhoef, G. E. G., Thomas, J., Vandenberghe, P., & Wolf‐Peeters, C. D. (2008) · Blood · doi:10.1182/blood-2007-10-118794 · Cited by 129
Genomic alterations in thyroid cancer: biological and clinical insights
Landa, I., & Cabanillas, M. E. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00920-6 · Cited by 134
Biology of Osteogenic Sarcoma
Wang, L. L. (2005) · The Cancer Journal · doi:10.1097/00130404-200507000-00005 · Cited by 126
Structure and Function of Latency-Associated Nuclear Antigen
Verma, S. C., Lan, K., & Robertson, E. S. (2006) · Springer eBooks · doi:10.1007/978-3-540-34344-8_4 · Cited by 128
The cancer biology of whole-chromosome instability
Duijf, P. H. G., & Benezra, R. (2013) · Oncogene · doi:10.1038/onc.2012.616 · Cited by 125
Identification and Characterization of ERK MAP Kinase Phosphorylation Sites in Smad3
Matsuura, I., Wang, G., He, D., & Liu, F. (2005) · Biochemistry · doi:10.1021/bi050560g · Cited by 126

Authors: Sherr, C. J., & McCormick, F.
Affiliations: St. Jude Children's Research Hospital (US)
University of California, San Francisco (US)
Corresponding author: Sherr, Charles J
ORCID: Sherr, Charles J
McCormick, Frank
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2002-08
Volume: 2
Issue: 2
Pages: 103-112
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/s1535-6108(02)00102-2
OpenAlex: W1992708996
Cited by: 1,690
References: 122
Citations by year: 2026: 31 · 2025: 40 · 2024: 36 · 2023: 60 · 2022: 56 · 2021: 62 · 2020: 62 · 2019: 67 · 2018: 75 · 2017: 67 · 2016: 60 · 2015: 71 · 2014: 88 · 2013: 81 · 2012: 90
FWCI: 7.67
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 4003 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: retinoblastoma protein, p53, tumor suppressor, malignant transformation, signaling pathways, cancer etiology, tumor-specific therapy, oncogenic transformation
MeSH terms: Cell Cycle, DNA-Binding Proteins, Humans, Neoplasms, Transcription Factors, Signal Transduction, Tumor Suppressor Protein p53, Retinoblastoma Protein, Apoptosis, Cell Cycle Proteins, Cyclin-Dependent Kinase Inhibitor p16, E2F Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The RB and p53 pathways in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks